Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • AstraZeneca Buys Definiens in Bid for Ground-Up Co-Diagnostics Pipeline

    Nov 5, 2014, 09:05 AM by Michael Croft
    Bio-IT World News Brief | AstraZeneca announced that it has acquired Definiens, a diagnostics company specializing in image analysis software, as part of a strategy to refine its immuno-oncology programs.
    Full story
  • Cloud Pharmaceuticals Announces World-Class Board of Directors

    Nov 5, 2014, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, UNITED STATES - Nov 5, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it ratified its board of directors at its annual meeting on September 16, 2014
    Full story
  • Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis

    Nov 5, 2014, 00:00 AM by Michael Croft
    TOKYO, JAPAN - Nov 5, 2014 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc
    Full story
  • Know More about Single-Cell Sequencing to Achieve More Biology Findings

    Nov 5, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 5, 2014 - As cell is the basic unit of biology, more and more scientists are trying to separate, study and compare cells
    Full story
  • October News and Product Briefs

    Nov 4, 2014, 10:30 AM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including the GIANT Consortium's record-breaking GWAS, a new organ-on-a-chip company, and plenty of announcements from the annual meeting of the American Society for Human Genetics.
    Full story
  • SRA Joins the Global Alliance for Genomics and Health

    Nov 4, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Nov 4, 2014 -  SRA International, Inc., a leading provider of IT solutions and professional services to government organizations, announced that it has joined the Global Alliance for Genomics and Health (Global Alliance) as an Organizational Member
    Full story
  • Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring

    Nov 4, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Nov 4, 2014 - Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), today announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively
    Full story
  • PRESS RELEASE: NEW STARTUP ‘BIO DATA BRIDGES’ OFFERS LAB DATA MANAGEMENT HEALTH CHECK™

    Nov 4, 2014, 00:00 AM by Michael Croft
    SEATTLE, WA - Nov 4, 2014 - The challenge of future-proofing scientific data systems just got a lot easier for life science companies
    Full story
  • NCI Awards Contracts for Cancer Genomics Cloud Pilots

    Nov 3, 2014, 14:00 PM by Michael Croft
    Bio-IT World News Brief | The National Cancer Institute has chosen two academic institutes and one private company to develop separate compute infrastructures for the analysis of cloud-hosted genomics data generated by large, public projects.
    Full story
  • Jonathan Rothberg Pursues Mobile Ultrasound

    Nov 3, 2014, 11:20 AM by Michael Croft
    MIT Technology Review | Jonathan Rothberg, founder of both 454 Life Sciences and Ion Torrent, is touting a new startup from his 4Combinator tech incubator that is developing a low-cost ultrasound device to plug into a smartphone.
    Full story
  • A Brief Introduction of Creative Animodel’s Bioanalysis

    Nov 3, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
    Full story
  • RainDance Technologies Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors

    Nov 3, 2014, 00:00 AM by Michael Croft
    BILLERICA, MA - Nov 3, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Martin M
    Full story
  • A Brief Introduction of Creative Animodel’s Bioanalysis(2)

    Nov 3, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
    Full story
  • Certara Updates Its Industry-Leading PK/PD Phoenix Platform and Introduces Phoenix Quantum Packages for Enhanced Collaboration and Efficiency

    Nov 3, 2014, 00:00 AM by Michael Croft
    PRINCETON, NJ - Nov 3, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1
    Full story
  • In a Restless Preclinical Testing Market, Organs-on-Chips Company MIMETAS Is in Expansion Mode

    Oct 31, 2014, 09:30 AM by Michael Croft
    Bio-IT World | Dutch startup MIMETAS, whose microfluidics technology forms a platform for three-dimensional, multi-cell-type tissue cultures, is securing new funding and partnerships as it expands its line of drug screening models.
    Full story
  • Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology Platform for Enhancing Clinical Development

    Oct 30, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Oct 30, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company
    Full story
  • Expanding the Search for Knockout Mutations to the Human Population

    Oct 29, 2014, 08:40 AM by Michael Croft
    Nature News | With mass sequencing of humans now a practical reality, several large population studies are searching for people with rare mutations that completely knock out specific genes, to uncover these genes' functions and potentially new drug targets.
    Full story
  • Personalized medicine: Genomics helps BC pharmacists target the right drugs for the right patient

    Oct 28, 2014, 00:00 AM by Michael Croft
    VANCOUVER, BC, CANADA - Oct 28, 2014 - An exciting new research project that aims to make personalized medicine a reality for patients is launching in a number of community pharmacies across British Columbia
    Full story
  • KCR Eliminates the Burden of Paper with Cloud-Based Content Management Solution

    Oct 28, 2014, 00:00 AM by Michael Croft
    WARSAW, POLAND - Oct 28, 2014 - KCR, a European Contract Research Organization (CRO) operating across 19 European countries and in the US, has turned to the cloud in a move to improve cross-functional collaboration and trial operations
    Full story
  • Large Funding Round for Massachusetts Biotech Syros

    Oct 27, 2014, 08:45 AM by Michael Croft
    Xconomy | Syros Pharmaceuticals, a biotech focused on creating drugs that target gene expression regulatory pathways, has announced a $53 million Series B financing round.
    Full story
  • «
  • 391
  • 392 (current)
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398
  • 399
  • 400
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy